Veerhealth Signs Contract Manufacturing Deal with Top Marketplace
ECONOMY & POLICY

Veerhealth Signs Contract Manufacturing Deal with Top Marketplace

Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.

Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.

Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.

This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.

Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.

To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.

We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.

Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters."

For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.

Products / Services offered by Veerhealth Care:

Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.

White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.

Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.

Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.

Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.

VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.

The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.


Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters.For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.Products / Services offered by Veerhealth Care:Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.

Related Stories

Gold Stories

Next Story
Products

Koemmerling opens Navi Mumbai experience centre

Koemmerling, a brand of the profine Group, has expanded its presence in the Mumbai metropolitan region with the opening of a new experience centre in Navi Mumbai and launched its Allure S46 minimal sliding door system for the Indian market.Located in CBD Belapur, the facility was inaugurated by Peter Mrosik, Owner and CEO, profine Group, along with Farid Khan, Chairman and Managing Director, profine India, and Kamal Bajaj, CEO, profine India.The company said the new centre will showcase its portfolio of uPVC and aluminium window and door systems to architects, developers and homeowners.The ina..

Next Story
Products

India's waterproofing market nears Rs 150 bn milestone

India's waterproofing industry is approaching a market size of Rs 150 billion and is expected to surpass the $2 billion milestone, according to speakers at the 2nd India International Waterproofers Conference & Expo 2026 organised by the Waterproofers Association of India (WAI) in New Delhi.The two-day event brought together more than 20 speakers, 55 international delegates and 53 exhibition booths, with discussions focusing on climate-resilient construction, advanced waterproofing technologies and international collaboration.Inaugurating the event, Durga Shanker Mishra, former Secretary, ..

Next Story
Real Estate

Dilip Buildcon Q1 FY27 Revenue at Rs 23.78 billion

Dilip Buildcon Limited reported consolidated revenue from operations of Rs 2,378 crore in Q1 FY27, along with EBITDA of Rs 429 crore and profit after tax of Rs 128 crore.Consolidated EBITDA margin stood at 18.1%, improving from 17.1% in Q4 FY26. On a standalone basis, revenue from operations was Rs 1,930 crore, EBITDA stood at Rs 199 crore and PAT was Rs 39 crore, with an EBITDA margin of 10.3%.The company’s order book stood at Rs 27,691 crore as of 30 June 2026, compared with Rs 28,830 crore as of 31 March 2026. Roads and highways accounted for 17.1% of the order book, irrigation and water ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement